norverapamil has been researched along with Cardiac Hypertrophy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, P | 1 |
1 review(s) available for norverapamil and Cardiac Hypertrophy
| Article | Year |
|---|---|
Pharmacokinetics of calcium channel blocking agents.
Topics: Administration, Oral; Angina Pectoris; Atrial Fibrillation; Biological Availability; Cardiomegaly; Clinical Trials as Topic; Female; Humans; Hypertension; Injections, Intravenous; Kinetics; Liver Cirrhosis; Male; Middle Aged; Nifedipine; Verapamil | 1986 |
1 trial(s) available for norverapamil and Cardiac Hypertrophy
| Article | Year |
|---|---|
Pharmacokinetics of calcium channel blocking agents.
Topics: Administration, Oral; Angina Pectoris; Atrial Fibrillation; Biological Availability; Cardiomegaly; Clinical Trials as Topic; Female; Humans; Hypertension; Injections, Intravenous; Kinetics; Liver Cirrhosis; Male; Middle Aged; Nifedipine; Verapamil | 1986 |